Clinical Trial Update: SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tamoxifen with or without combination chemotherapy in postmenopausal women after breast cancer surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED